icon-folder.gif   Conference Reports for NATAP  
61th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2010
Back grey_arrow_rt.gif
Pharmacokinetics, Safety, and Tolerability of PSI-352938, a Novel Nucleotide Polymerase Inhibitor for HCV, Following Single Ascending Oral Doses in Healthy Subjects
  Reported by Jules Levin
AASLD 2010 Nov 2 Boston
William T. Symonds1, Jill M. Denning1, Efsevia Albanis1, Melanie T. Cornpropst1, Robert Wright2, Alexander Lai2, M. Michelle Berrey1 1. Pharmasset, Inc., Princeton, NJ, 2. Covance Clinical Research Unit, Inc, Madison, WI